{"text": ["Eli", "Lilly", "Stock", "Soars", "To", "96", "Composite", "Rating"], "created_at": "2021-08-16 21:18:00"}
{"text": ["Innovent's", "Sintilimab/Chemo", "Regime", "Shows", "Overall", "Survival", "Benefit", "In", "Gastric", "Cancer"], "created_at": "2021-08-16 12:24:54"}
{"text": ["Lilly's", "Lebrikizumab", "Shows", "Clinical", "Benefit", "In", "Late-Stage", "Atopic", "Eczema", "Trials"], "created_at": "2021-08-16 12:12:16"}
{"text": ["FDA", "approves", "Lyumjev\u00ae", "(insulin", "lispro-aabc", "injection)", "100", "units/mL", "for", "use", "in", "insulin", "pumps"], "created_at": "2021-08-16 11:00:00"}
{"text": ["Lilly's", "lebrikizumab", "significantly", "improved", "skin", "clearance", "and", "itch", "in", "people", "with", "moderate-to-severe", "atopic", "dermatitis", "in", "two", "Phase", "3", "trials"], "created_at": "2021-08-16 06:00:00"}
